Cargando…
Progression of Fibrinogen Decrease during High Dose Tigecycline Therapy in Critically Ill Patients: A Retrospective Analysis
Tigecycline is a novel glycylcycline broad-spectrum antibiotic offering good coverage for critically ill patients experiencing complicated infections. A known side effect is a coagulation disorder with distinct hypofibrinogenemia. To date, the information on possible risk factors and outcomes is spa...
Autores principales: | Treml, Benedikt, Rajsic, Sasa, Hell, Tobias, Fries, Dietmar, Bachler, Mirjam |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8537220/ https://www.ncbi.nlm.nih.gov/pubmed/34682825 http://dx.doi.org/10.3390/jcm10204702 |
Ejemplares similares
-
Tigecycline Interferes with Fibrinogen Polymerization Independent of Peripheral Interactions with the Coagulation System
por: Brandtner, Anna, et al.
Publicado: (2020) -
Small Drainage Volumes of Pleural Effusions Are Associated with Complications in Critically Ill Patients: A Retrospective Analysis
por: Treml, Benedikt, et al.
Publicado: (2021) -
Diagnostic Modalities in Critical Care: Point-of-Care Approach
por: Rajsic, Sasa, et al.
Publicado: (2021) -
Influence of factor XII deficiency on activated partial thromboplastin time (aPTT) in critically ill patients
por: Bachler, Mirjam, et al.
Publicado: (2019) -
Fibrinogen (FI)
por: Fries, Dietmar, et al.
Publicado: (2015)